Skip to content
Homepage
Author:
ZENTALIS PHARMACEUTICALS
Posted Date:
September 2, 2026
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
ZENTALIS PHARMACEUTICALS
September 2, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ZENTALIS PHARMACEUTICALS
September 1, 2026
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
ZENTALIS PHARMACEUTICALS
August 17, 2026
